关于
Apex AI Institute Inc. 是一家依据纽约州非营利法人法组建的国内非营利法人。
我们的创始董事——Dr. Lun-Hsiang Yuan 和 J. Michael Hwang——均为无偿任职。他们的专业背景涵盖泌尿肿瘤学、机器人手术、临床 AI 系统、企业财务和组织治理。
当前聚焦两大公益支柱：加速药物开发研究（项目 A）和社区可及的医学 AI 教育（项目 C 和 D）。其他愿景方向属于未来工作；请参阅 我们的使命 了解全貌。
我们以公益孵化器模式运营：公益研究留在 AAI 内部，如果某项目发展出商业潜力，可能会剥离至独立注册的营利实体。任何此类转型均须经董事会按公平市场价值条款批准并完整记录。
How we work
The operating posture behind every program — built by the people who teach it, shared without fee, replicable by anyone.
Programs are designed by the directors who will teach and publish them — not outsourced to third-party curriculum vendors.
Every collaboration — academic, community, or institutional — is non-exclusive. Partners can replicate anything we build.
Syllabi, code, recordings, and methods manuscripts ship under permissive licenses, with no paywall or approval gate.
Meet a director
Deputy Director of Urology, National Taiwan University Hospital, Yunlin Branch
Robotic urologic surgeon and clinical-AI researcher. Leads Asia's highest-volume Senhance robotic surgery program and co-leads AAI's Applied AI Literacy program. First author of the 2025 WJMH paper on LLM-based prostate-cancer risk assessment.
See the full board →